Nanomedicine-based combination therapies for overcoming temozolomide resistance in glioblastomas

Glioblastoma (GBM) is the most common malignant brain tumor. Although current treatment strategies, including surgery, chemotherapy, and radiotherapy, have achieved clinical effects and prolonged the survival of patients, the gradual development of resistance against current therapies has led to a h...

Full description

Bibliographic Details

Published in:	Cancer Biology & Medicine
Main Authors:	Chun Wang, Qiushi Li, Jian Xiao, Yang Liu
Format:	Article
Language:	English
Published:	China Anti-Cancer Association 2023-05-01
Subjects:	combination therapy drug resistance glioblastoma nanotechnology temozolomide
Online Access:	https://www.cancerbiomed.org/content/20/5/325